CD47 and breast cancer: Thus, HER2-expressing tumor cells including the HER2-expressing cancer stem cells26 may take advantage of CD47-mediated immunosuppression to not only survive radiation but also escape immunosurveillance, contributing to the aggressive phenotype of radioresistant BC.